JPH09509415A - ワクチンアジュバントとしてのプロラクチン - Google Patents

ワクチンアジュバントとしてのプロラクチン

Info

Publication number
JPH09509415A
JPH09509415A JP7521414A JP52141495A JPH09509415A JP H09509415 A JPH09509415 A JP H09509415A JP 7521414 A JP7521414 A JP 7521414A JP 52141495 A JP52141495 A JP 52141495A JP H09509415 A JPH09509415 A JP H09509415A
Authority
JP
Japan
Prior art keywords
prolactin
composition
human
vaccine
cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7521414A
Other languages
English (en)
Japanese (ja)
Inventor
リチャーズ，スーザン
カプラン，ジョアンヌ
モスチッキ，リチャード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of JPH09509415A publication Critical patent/JPH09509415A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57554—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP7521414A 1994-02-14 1995-02-14 ワクチンアジュバントとしてのプロラクチン Pending JPH09509415A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19635094A 1994-02-14 1994-02-14
US08/196,350 1994-02-14
PCT/US1995/001866 WO1995021625A1 (fr) 1994-02-14 1995-02-14 Prolactine servant d'adjuvant pour vaccin

Publications (1)

Publication Number Publication Date
JPH09509415A true JPH09509415A (ja) 1997-09-22

Family

ID=22725034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7521414A Pending JPH09509415A (ja) 1994-02-14 1995-02-14 ワクチンアジュバントとしてのプロラクチン

Country Status (5)

Country Link
EP (1) EP0952846A1 (fr)
JP (1) JPH09509415A (fr)
AU (1) AU700104B2 (fr)
CA (1) CA2183260A1 (fr)
WO (1) WO1995021625A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040848A1 (fr) * 1996-04-30 1997-11-06 Genzyme Corporation Utilisation de la prolactine comme un antagoniste de tgf-beta
JP2001516341A (ja) * 1997-01-21 2001-09-25 ジェンザイム・コーポレーション 造血細胞の増強
DE69933707T2 (de) 1999-08-25 2007-08-23 Accuplex, L.L.C. Serum amyloid a als marker für entzündungsreaktion, milchqualität und die anwesenheit von kolostrum in milch
CA2387907A1 (fr) 1999-10-22 2001-05-03 The Board Of Regents Of The University Of Nebraska Isoforme de serum amyloide a decouverte dans le colostrum
WO2003044174A2 (fr) * 2001-11-21 2003-05-30 Board Of Regents Of The University Of Nebraska Sequences de promoteurs a3 amyloides seriques associees a des mammiferes et leurs utilisations
US7368546B2 (en) 2003-01-21 2008-05-06 The Board Of Regents Of The University Of Nebraska Human SAA3 nucleic acid molecule, protein, and methods of use for same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725549A (en) * 1980-09-22 1988-02-16 The Regents Of The University Of California Human and rat prolactin and preprolactin cloned genes
US5028591A (en) * 1987-09-14 1991-07-02 Pitman-Moore, Inc. Method for stimulating the immune system
GB8821656D0 (en) * 1988-09-15 1988-10-12 Health Lab Service Board Pharmaceutical compositions for eliciting immunostimulant effect

Also Published As

Publication number Publication date
AU1876595A (en) 1995-08-29
CA2183260A1 (fr) 1995-08-17
EP0952846A1 (fr) 1999-11-03
EP0952846A4 (fr) 1999-11-03
WO1995021625A1 (fr) 1995-08-17
AU700104B2 (en) 1998-12-24

Similar Documents

Publication Publication Date Title
JP2017055772A (ja) Ｂ型肝炎ウイルスコアタンパク質をコードする核酸分子およびそれを含むワクチン
JPH09509568A (ja) 精子透明帯結合タンパク質の自己抗原エピトープに対応する精子抗原
KR20200001671A (ko) 중증 열성 혈소판 감소 증후군(sfts) 바이러스 감염 질환 예방 또는 치료용 백신 조성물
US20020198168A1 (en) Vaccine against Mycobacterial infections
US20020111323A1 (en) Introduction of naked DNA or RNA encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
CN111944023B (zh) 一种抗o型口蹄疫的疫苗组合物及其制备方法和应用
JPH11502533A (ja) インターロイキン−１０を用いる、特定の抗原に対する抗体応答を増強するための方法
KR100773390B1 (ko) 단순 포진 바이러스 백신 키트
EP1266662A2 (fr) Vaccins de peptides de synthése pour prevenir les caries dentaires
CA2180309A1 (fr) Vaccin contre la coccidiose de la volaille
CA2086739A1 (fr) Vaccin a base de glycoproteines contre le ehv-4
JPH09509415A (ja) ワクチンアジュバントとしてのプロラクチン
US6221664B1 (en) Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method
EP0603406A1 (fr) Antigene de mycoplasme aviaire, son gene, vecteur recombine contenant ledit gene, et vaccin prepare a l'aide de celui-ci
US7910110B2 (en) Bacteriophage-mediated immunisation against hepatitis
Kim et al. Determination of T cell epitopes on the S1 subunit of pertussis toxin.
US20240123052A1 (en) Vaccines For Recurrent Respiratory Papillomatosis And Methods of Using the Same
CN121758573A (zh) 猫疱疹病毒i型抗原蛋白、亚单位疫苗及其应用
WO2022211482A1 (fr) Vaccin contre un virus fondé sur une ingénierie de surface virale fournissant une immunité accrue
NZ226272A (en) Method for induction of a cytotoxic t-cell response
JP2588596B2 (ja) オーエスキー病のサブユニットワクチン、及び製造方法
CN120058961A (zh) 猪丹毒丝菌抗原重组蛋白nfliC-SpaA及其产品与应用
WO2000025820A1 (fr) Composes et procedes destines a l'immunisation genetique
Miyagi et al. The Timing of GM-CSF Expression Plasmid
HK1036303A (en) Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate